Schedule 13G ownership disclosure

Treace Medical Concepts Inc

Common stock, $0.001 par value · CUSIP: 89455T109

Event date: 2025-05-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Gagnon Securities LLC

    Shares: 2,709,970.00 · Class: 4.3%

  • Gagnon Advisors, LLC

    Shares: 830,270.00 · Class: 1.3%

  • Neil Gagnon

    Shares: 3,979,454.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001344676-25-000030
Form type
SCHEDULE 13G
Filer
GAGNON SECURITIES LLC
CIK
CIK 1125725
Filed
May 15, 2025
Reporting period
May 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub